Core Viewpoint - Luyuan Pharmaceutical (002788.SZ) is focusing on innovation and the cultivation of new technologies and models, with products in the fields of electrocardiograms and fetal heart monitoring having received medical device registration certification and initiated sales [1] Group 1 - The company emphasizes strengthening innovation leadership and focusing on practical implementation [1] - Self-developed products in the electrocardiogram and fetal heart monitoring sectors have been certified and are now in the sales phase [1] - The sales revenue from these products is currently small and has a limited impact on the company's overall performance [1] Group 2 - There are risks and challenges associated with the market expansion of these products, which investors should be aware of [1]